文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

EQ-5D-5L 比 EQ-5D-3L 更能反映白内障手术治疗获益。

EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

机构信息

Department of Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore.

Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.

出版信息

Patient. 2019 Aug;12(4):383-392. doi: 10.1007/s40271-018-00354-7.


DOI:10.1007/s40271-018-00354-7
PMID:30607809
Abstract

BACKGROUND: It is not clear whether 5-level EQ-5D (EQ-5D-5L) utilities based on recently developed value sets are more responsive than 3-level EQ-5D (EQ-5D-3L) utilities. OBJECTIVES: The study aims were to compare (1) the responsiveness of EQ-5D-5L and EQ-5D-3L utilities and (2) the responsiveness of these utilities with the Short Form-6 Dimension (SF-6D) and Health Utilities Index Mark 3 (HUI3) utilities to the treatment benefit of cataract surgery. METHODS: A total of 148 patients were interviewed before and after their cataract surgery using EQ-5D-3L, EQ-5D-5L, SF-6D, and HUI3. Responsiveness was assessed for all measures using the mean change (post-treatment-pre-treatment), standardized effect size (SES), standardized response mean (SRM), and F-statistic. RESULTS: Using the Singapore value sets, mean change for EQ-5D-3L and EQ-5D-5L utilities was 0.016 and 0.028, SES was 0.097 and 0.199; SRM was 0.091 and 0.196; and F-statistic was 1.2 and 5.7, respectively. Similar trends were observed using the UK/England EQ-5D value sets, although the magnitude was slightly smaller. The mean change, SES, SRM and F-statistics for SF-6D (UK value set) were 0.020, 0.234, 0.249, and 9.2, respectively. The values of mean change, SES, SRM and F-statistics for HUI3 (Canada value set) were 0.080, 0.472, 0.474, and 33.3, respectively. CONCLUSIONS: The EQ-5D-5L utilities tend to be more responsive than the EQ-5D-3L utilities to treatment benefits of cataract surgery. The HUI3 utilities are more responsive than both the EQ-5D-5L and SF-6D, and SF-6D utilities may be slightly more responsive than the EQ-5D-5L for assessing patients undergoing cataract surgery.

摘要

背景:目前尚不清楚基于最近开发的价值体系的 5 级 EQ-5D(EQ-5D-5L)效用是否比 3 级 EQ-5D(EQ-5D-3L)效用更具反应性。

目的:本研究旨在比较(1)EQ-5D-5L 和 EQ-5D-3L 效用的反应性,以及(2)这些效用与短期表格-6 维度(SF-6D)和健康效用指数马克 3(HUI3)效用对白内障手术治疗效果的反应性。

方法:共 148 例患者在接受白内障手术后使用 EQ-5D-3L、EQ-5D-5L、SF-6D 和 HUI3 进行了采访。使用平均变化(治疗后-治疗前)、标准化效应量(SES)、标准化反应均值(SRM)和 F 统计量评估所有指标的反应性。

结果:使用新加坡价值体系,EQ-5D-3L 和 EQ-5D-5L 效用的平均变化分别为 0.016 和 0.028,SES 分别为 0.097 和 0.199;SRM 分别为 0.091 和 0.196;F 统计量分别为 1.2 和 5.7。使用英国/英格兰 EQ-5D 价值体系观察到类似的趋势,尽管幅度略小。SF-6D(英国价值体系)的平均变化、SES、SRM 和 F 统计量分别为 0.020、0.234、0.249 和 9.2。HUI3(加拿大价值体系)的平均变化、SES、SRM 和 F 统计量分别为 0.080、0.472、0.474 和 33.3。

结论:EQ-5D-5L 效用比白内障手术治疗效果更能反映 EQ-5D-3L 效用。HUI3 效用比 EQ-5D-5L 和 SF-6D 更具反应性,而 SF-6D 效用在评估接受白内障手术的患者时可能比 EQ-5D-5L 更具反应性。

相似文献

[1]
EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Patient. 2019-8

[2]
A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.

Eur J Health Econ. 2020-6

[3]
Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients.

Qual Life Res. 2020-2-20

[4]
Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).

Eur J Health Econ. 2015-12

[5]
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.

J Med Econ. 2022

[6]
Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.

Health Qual Life Outcomes. 2021-4-17

[7]
Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.

Med Decis Making. 2018-11

[8]
Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.

Qual Life Res. 2015-6

[9]
Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.

Spine (Phila Pa 1976). 2019-6-1

[10]
A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population.

Expert Rev Pharmacoecon Outcomes Res. 2021-8

引用本文的文献

[1]
Developing an EQ-5D-5L Value Set for Singapore.

Pharmacoeconomics. 2025-8-29

[2]
Validation and comparison of EQ-5D-5L and SF-6Dv1 in myopic patients requiring corneal refractive surgery in China.

Health Qual Life Outcomes. 2025-8-22

[3]
Correlations among nicotine dependence, health-related quality of life, and depression in current smokers: a cross-sectional study with a mediation model.

Front Psychiatry. 2024-8-27

[4]
Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada.

Qual Life Res. 2023-8

[5]
Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.

Pharmacoeconomics. 2022-11

[6]
Comparison of EQ-5D-3L and 5L versions following operative fixation of closed ankle fractures.

Qual Life Res. 2022-7

[7]
Macular Edema and Visual Acuity Observation after Cataract Surgery in Patients with Diabetic Retinopathy.

J Healthc Eng. 2022

[8]
Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China.

Qual Life Res. 2022-5

[9]
Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.

Health Qual Life Outcomes. 2021-5-28

[10]
Psychometric properties of the EQ-5D-5L: a systematic review of the literature.

Qual Life Res. 2021-3

本文引用的文献

[1]
Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments.

Eur J Health Econ. 2018-6-14

[2]
A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D.

Pharmacoeconomics. 2018-6

[3]
Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.

Pharmacoeconomics. 2018-6

[4]
Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.

Pharmacoeconomics. 2018-6

[5]
EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.

Value Health. 2018-1

[6]
Valuing health-related quality of life: An EQ-5D-5L value set for England.

Health Econ. 2018-1

[7]
Patient-reported outcome measuring tools in cataract surgery: Clinical comparison at a tertiary hospital.

J Cataract Refract Surg. 2016-12

[8]
The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.

Value Health Reg Issues. 2016-5

[9]
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes.

Pharmacoeconomics. 2016-10

[10]
A Vision "Bolt-On" Item Could Increase the Discriminatory Power of the EQ-5D Index Score.

Value Health. 2015-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索